Polar Asset Management Partners’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-148,800
| Closed | -$2.65K | – | 1251 |
|
|
2022
Q4 | $2.65K | Hold |
148,800
| – | – | ﹤0.01% | 1121 |
|
|
2022
Q3 | $12K | Hold |
148,800
| – | – | ﹤0.01% | 1185 |
|
|
2022
Q2 | $12K | Hold |
148,800
| – | – | ﹤0.01% | 1208 |
|
|
2022
Q1 | $30K | Hold |
148,800
| – | – | ﹤0.01% | 1050 |
|
|
2021
Q4 | $80K | Sell |
148,800
-26,300
| -15% | -$14.1K | ﹤0.01% | 1100 |
|
|
2021
Q3 | $105K | Hold |
175,100
| – | – | ﹤0.01% | 1016 |
|
|
2021
Q2 | $133K | Buy |
+175,100
| New | +$133K | ﹤0.01% | 941 |
|